New Report by Global Health Progress Highlights Innovative Solutions to Improve Access to Healthcare in China

New Report by Global Health Progress Highlights Innovative Solutions to Improve Access to Healthcare in China

Collaboration between Chinese leaders and biopharmaceutical companies is key in addressing access to healthcare issues

Global Health Progress' recently released report, Innovative Solutions to Improving Health in China, summarizes the important role access to drugs, access to medicines and overall access to healthcare plays across the world, especially in China.

Notably, the report points out China's, as in other countries around the world, population faces the challenge of debilitating and deadly infectious and chronic diseases. For instance, in China, the HIV infection rate has been rising sharply, making HIV/AIDS the country's leading cause of death among infectious diseases. China also has the second largest number of tuberculosis cases in the world, and its levels of drug-resistant tuberculosis are nearly twice the global average. More than half the population (700 million Chinese) has had hepatitis B, and the number of patients with diabetes is growing faster in China than anywhere else in the world. The country's estimated 35 million to 40 million diabetics now constitute 20 percent of the world's total.

In addition to emphasizing the importance of access to prescription medications, and other healthcare solutions, the report highlights how China's leaders have recognized the need to ensure safe, efficient, affordable access to healthcare for all of its citizens. This includes ensuring access to quality health services and an ability to rapidly respond to public health emergencies, such as the avian flu. While patient assistance programs for patented and unpatented medicines have helped reduce barriers to access to medicines, they have limited impact if challenges within a health system work to keep the medicine from reaching patients. Partnerships between industry and government are essential to effectively reach patients and meet healthcare objectives and leaders in China face complex health challenges with limited local resources.

Thus, biopharmaceutical companies have worked with the Chinese government, Chinese organizations, international agencies, and local leaders for decades in building effective, sustainable programs to address many of these challenges and improve the health of Chinese citizens. Given this shared commitment, the potential for greater collaboration, and the desire to do more, biopharmaceutical companies formed Global Health Progress.

The Global Health Progress is committed to working with leaders in China to strengthen collaboration with research-based biopharmaceutical companies and other global health leaders to reduce the burden of disease and strengthen health systems. Building sustainable, innovative solutions to this serious situation and improving access to healthcare calls for joint action among local leaders and diverse global stakeholders. The examples described in the full report demonstrate the progress made and the potential for new initiatives.

POST COMMENT

Success vs Economy? What a joke Global Success Club - How to Earn Money with GSC Root Cause Analysis - The Heart of a Successful CAPA Program - Webinar By GlobalCompliancePanel Rising trend in global pulp prices view different opinions - the price of paper, development trend - Cheap Checks Free Shipping and Handling Sea container shipping The globally-wealthy pick Mumbai, Shanghai and Sao Paolo as the world's future cities Does Globalization Spell Our Doom What Evangelicals Have To Say About Global Warming Lower paper industry is expected to last two years, the economy - paper, paper industry - Paper Indu Global Success Club - Legit Online Business A Logistical and Ethical View of Transfer Pricing in a Global Market Purchasing A Posturepedic Pillow Top Mattress